DeepMed Research

Rigshospitalet

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Private

Established: 1757-03-30

Employees: 10K

Market Cap: -

Website: http://www.rigshospitalet.dk

Clinical Trials

Early Detection of de Novo Cancer in Liver Transplant Recipients

Completed

Conditions: De Novo Cancer
Liver Transplant Disorder

First Posted Date: 2022-08-08

Last Posted Date: 2022-08-08

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 3628

Registration Number: NCT05492617

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Not Applicable

Completed

Conditions: Interferon Deficiency
Systemic Lupus Erythematosus

Interventions: Behavioral: High Intensity Interval Training

First Posted Date: 2022-07-28

Last Posted Date: 2025-04-27

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 55

Registration Number: NCT05478018

Locations: 🇩🇰
Center for Physical Activity Research, Copenhagen, Denmark

Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip

Not Applicable

Recruiting

Conditions: Metastatic Cancer to the Hip

Interventions: Other: Constrained Liner
Other: Dual Mobility

First Posted Date: 2022-07-18

Last Posted Date: 2024-04-23

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 146

Registration Number: NCT05461313

Locations: 🇩🇰
Department of Orthopedic Surgery, Rigshospitalet, Copenhagen, Denmark

Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial

Not Applicable

Active, not recruiting

Conditions: Affective Disorder
Psychosis

Interventions: Behavioral: Supervised exercise

First Posted Date: 2022-07-18

Last Posted Date: 2025-04-30

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 400

Registration Number: NCT05461885

Locations: 🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇩🇰
Mental Health Centre Copenhagen, Copenhagen, Denmark

and more 1 locations

Relieving the Bile Ducts Prior to Pancreatoduodenectomy

Completed

Conditions: Surgery-Complications
Biliary Fistula
Pancreas Cancer

Interventions: Procedure: Preoperative biliary drainage (ERC og PTC-aided)

First Posted Date: 2022-06-28

Last Posted Date: 2022-06-28

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 722

Registration Number: NCT05434520

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Capitol, Denmark

Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Venetoclax

First Posted Date: 2022-06-24

Last Posted Date: 2022-06-24

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 117

Registration Number: NCT05431257

Locations: 🇩🇰
Department of Hematology, Rigshospitalet, Copenhagen, Denmark

The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

Active, not recruiting

Conditions: AIDS
HIV-1-infection
Inflammation

First Posted Date: 2022-06-16

Last Posted Date: 2025-04-11

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 991

Registration Number: NCT05421286

Locations: 🇧🇪
CHU Saint-Pierre Hospital, Brussels, Belgium
🇩🇰
Hvidovre Universitets Hospital, Hvidovre, Denmark
🇱🇺
Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg

and more 19 locations

Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis

Recruiting

Conditions: Aortic Valve Stenosis
Cardiac Magnetic Resonance
T1 Mapping
Aortic Valve Replacement
Myocardial Fibrosis

Interventions: Procedure: Aortic valve replacement

First Posted Date: 2022-06-03

Last Posted Date: 2023-11-18

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 60

Registration Number: NCT05404100

Locations: 🇩🇰
Rigshospitalet, Copenhagen O, Denmark

BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease

Recruiting

Conditions: Biliary Atresia
Cognitive Impairment

Interventions: Other: Neurocognitive monitoring

First Posted Date: 2022-06-01

Last Posted Date: 2022-06-01

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 100

Registration Number: NCT05399745

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Phase 2

Conditions: Neuroendocrine Tumors
Neuroendocrine Carcinoma Metastatic
Lymphoma
Sarcoma
Breast Cancer
Neuroendocrine Carcinoma

Interventions: Drug: 18F-FDG
Drug: Injection of hyperpolarized [1-13C]Pyruvate
Procedure: PET/MR/MRS/MRSI scanning

First Posted Date: 2022-05-31

Last Posted Date: 2024-05-14

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 15

Registration Number: NCT05396118

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy